These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 19531930

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Genotyping of viral glycoprotein B (gB) in hematopoietic stem cell transplant recipients with active cytomegalovirus infection: analysis of the impact of gB genotypes on the patients' outcome].
    Roubalová K, Strunecký O, Zufanová S, Procházka B, Vitek A.
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):92-9. PubMed ID: 20586171
    [Abstract] [Full Text] [Related]

  • 4. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
    Gourlain K, Salmon D, Gault E, Leport C, Katlama C, Matheron S, Costagliola D, Mazeron MC, Fillet AM, Predivir Study Group, CMV AC11 Study Group.
    J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
    Mihăilescu R, Arama V, Paraschiv S, Streinu-Cercel A, Oţelea D, Munteanu D, Iosipenco M, Chiotan C, Benea OE, Mărdărescu M, Rădulescu M, Hristea A, Ungurianu R, Aramă SS, Cercel AS, Călin R, Băicuş C.
    Rom J Intern Med; 2008 Mar; 46(4):305-11. PubMed ID: 19480296
    [Abstract] [Full Text] [Related]

  • 7. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [Abstract] [Full Text] [Related]

  • 8. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Rudent A, Lantz O, Lecointe D, Furlan V, Delfraissy JF, Offret H.
    J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
    [Abstract] [Full Text] [Related]

  • 9. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS.
    AIDS; 2008 Nov 12; 22(17):2371-80. PubMed ID: 18981777
    [Abstract] [Full Text] [Related]

  • 10. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A.
    Clin Infect Dis; 2009 Oct 15; 49(8):1160-6. PubMed ID: 19751151
    [Abstract] [Full Text] [Related]

  • 11. HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals.
    Gibellini D, Borderi M, De Crignis E, Cicola R, Cimatti L, Vitone F, Chiodo F, Re MC.
    J Infect; 2008 Mar 15; 56(3):219-25. PubMed ID: 18276011
    [Abstract] [Full Text] [Related]

  • 12. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S, Garrido C, Youngpairoj AS, McNulty A, Zahonero N, Corral A, Heneine W, de Mendoza C, García-Lerma JG.
    AIDS; 2007 Nov 30; 21(18):2503-11. PubMed ID: 18025887
    [Abstract] [Full Text] [Related]

  • 13. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
    Resino S, Larrú B, Maria Bellón J, Resino R, de José MI, Navarro M, Léon JA, Ramos JT, Mellado MJ, Muñoz-Fernández MA.
    BMC Infect Dis; 2006 Jul 11; 6():107. PubMed ID: 16834769
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus glycoprotein B genotypes and central nervous system disease in AIDS patients.
    Vilas Boas LS, de Souza VA, Penalva de Oliveira AC, Rodriguez Viso AT, Nascimento Filho AM, Nascimento MC, Pannuti CS.
    J Med Virol; 2003 Nov 11; 71(3):404-7. PubMed ID: 12966546
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M, Gerevini S, Bestetti A, Pedale R, Sala S, Sala S, Lazzarin A, Cinque P.
    Clin Infect Dis; 2005 Mar 01; 40(5):738-44. PubMed ID: 15714422
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
    Landman R, Capitant C, Descamps D, Chazallon C, Peytavin G, Katlama C, Pialoux G, Bentata M, Brun-Vézinet F, Aboulker JP, Yéni P, ANRS 127 Study Group.
    J Antimicrob Chemother; 2009 Jul 01; 64(1):118-25. PubMed ID: 19420019
    [Abstract] [Full Text] [Related]

  • 18. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy.
    Geretti AM, Smith C, Haberl A, Garcia-Diaz A, Nebbia G, Johnson M, Phillips A, Staszewski S.
    Antivir Ther; 2008 Jul 01; 13(7):927-36. PubMed ID: 19043927
    [Abstract] [Full Text] [Related]

  • 19. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction.
    Francisci D, Giannini S, Baldelli F, Leone M, Belfiori B, Guglielmini G, Malincarne L, Gresele P.
    AIDS; 2009 Mar 13; 23(5):589-96. PubMed ID: 19177019
    [Abstract] [Full Text] [Related]

  • 20. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L, Ryder LP, Albrecht-Beste E, Jensen FK, Nielsen SD.
    Scand J Immunol; 2009 Dec 13; 70(6):608-13. PubMed ID: 19906203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.